1. Home
  2. KFRC vs KMDA Comparison

KFRC vs KMDA Comparison

Compare KFRC & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kforce Inc.

KFRC

Kforce Inc.

HOLD

Current Price

$43.31

Market Cap

499.7M

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$8.31

Market Cap

488.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KFRC
KMDA
Founded
1962
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
499.7M
488.6M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
KFRC
KMDA
Price
$43.31
$8.31
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$39.67
$14.00
AVG Volume (30 Days)
322.3K
33.7K
Earning Date
04-27-2026
05-13-2026
Dividend Yield
3.42%
3.08%
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$1,329,007,000.00
N/A
Revenue This Year
$2.78
$13.94
Revenue Next Year
$4.32
$9.84
P/E Ratio
$96.28
$24.59
Revenue Growth
N/A
N/A
52 Week Low
$24.49
$6.50
52 Week High
$47.50
$9.35

Technical Indicators

Market Signals
Indicator
KFRC
KMDA
Relative Strength Index (RSI) 70.86 49.64
Support Level $26.60 $7.96
Resistance Level $47.48 $8.40
Average True Range (ATR) 2.12 0.17
MACD 1.33 0.00
Stochastic Oscillator 75.82 45.78

Price Performance

Historical Comparison
KFRC
KMDA

About KFRC Kforce Inc.

Kforce Inc is a solutions firm specializing in technology, finance, accounting, and other professional staffing services. The company operates two business segments: the Technology segment, which provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. The FA segment offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting, business and cost analysis; and taxation and treasury. The majority of revenue is earned through the Technology segment.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: